Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02657954 · ClinicalTrials.gov registry record · NA

ASPIRE Cognitive Enhancement Study

A NA study of Homelessness and Mental Health Conditions, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
79
Enrollment target
1
Study location

NCT02657954: Completed NA study of Homelessness and Mental Health Conditions, sponsored by VA Office of Research and Development.

NCT02657954 is a NA study of Homelessness and Mental Health Conditions that has completed, run by VA Office of Research and Development. The registered enrollment target is 79 participants, below the 442-participant average among 8 other Homelessness trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02657954, a NA study of Homelessness and Mental Health Conditions, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
79 participants
Enrollment target
1
Study location

Study Summary

Cognitive impairments are present in up to 80% of homeless individuals, and may contribute to homelessness in Operation Enduring Freedom / Operation Iraqi Freedom / Operation New Dawn (OEF/OIF/OND) Veterans. The investigators propose to investigate these issues in homeless, treatment-seeking returning Veterans, who arguably face multiple potential barriers to recovery and reintegration, and with whom there is the greatest opportunity to prevent long-term homelessness. The investigators plan to conduct a 15-week randomized controlled trial of an evidence-based, 10-week Compensatory Cognitive Training (CCT) intervention vs. an education control condition to examine the effects of cognitive rehabilitation in this Veteran population. The investigators expect CCT-associated improvements in cognition and functional skills and generalization to reduced levels of disability, along with improved community reintegration outcomes. By attending to and treating cognitive impairments, the investigators can potentially prevent future homelessness and its negative health consequences, resulting in both healthcare cost savings and improved quality of life for Veterans.

Primary Outcome

Global Deficit Score (composite score) from MATRICS Consensus Cognitive Battery plus Delis-Kaplan Executive Function System (D-KEFS) subtests (Verbal Fluency, Color-Word Interference), Trail Making Test, Part B Global deficit score range = 0-5, lower scores are better, higher scores are worse. For change in global deficit score, higher is better.

Interventions

  • BEHAVIORAL CCT
  • BEHAVIORAL HCE

Study Locations (1)

California

  • VA San Diego Healthcare System, San Diego, CA - San Diego

Trial Details

FieldValue
Enrollment Target 79 participants
Start Date 2016-07-01
Est. Completion 2022-03-31
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT02657954 record still lists

NCT02657954 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 79 participants, a relatively small participant target, below the 442-participant average among 8 other Homelessness trials with a reported enrollment target (82% lower).

The record links to 2 conditions, with Homelessness appearing as the primary indexed condition, and to 2 interventions - of which CCT is the first listed.

NCT02657954 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02657954 about?

NCT02657954 is a clinical study titled "ASPIRE Cognitive Enhancement Study". Cognitive impairments are present in up to 80% of homeless individuals, and may contribute to homelessness in Operation Enduring Freedom / Operation Iraqi Freedom / Operation New Dawn (OEF/OIF/OND) Veterans. The investigators propose to investigate these issues in homeless, treatment-seeking returni...

What is the current status of trial NCT02657954?

This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2016-07-01. Estimated completion is 2022-03-31.

What conditions does trial NCT02657954 study?

This clinical trial studies the following conditions: Homelessness, Mental Health Conditions.

What interventions are being tested in trial NCT02657954?

The interventions under investigation include: CCT (BEHAVIORAL), HCE (BEHAVIORAL).

Who is sponsoring clinical trial NCT02657954?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02657954 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Homelessness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02657954's enrollment target sits among peer trials

79 8th of 8 higher than 1 of 8 other Homelessness trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Homelessness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05798897 · 79 participants · Phase 1

    Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

  • NCT06042439 · 79 participants · NA

    AM vs PM Exercise Training

  • NCT06223555 · 79 participants · NA

    Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02657954, the US trial registry maintained by the National Library of Medicine. NCT02657954 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.